Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020113197 - VIRAL FORMULATIONS CONTAINING AMINO ACIDS

Publication Number WO/2020/113197
Publication Date 04.06.2020
International Application No. PCT/US2019/063898
International Filing Date 30.11.2019
IPC
A61K 39/285 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
275Poxviridae, e.g. avipoxvirus
285Vaccinia virus or variola virus
A61K 47/18 2017.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
16containing nitrogen
18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
A61K 47/26 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
CPC
A01N 1/02
AHUMAN NECESSITIES
01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
1Preservation of bodies of humans or animals, or parts thereof
02Preservation of living parts
A61K 39/285
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
275Poxviridae, e.g. avipoxvirus
285Vaccinia virus or variola virus
A61K 47/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
16containing nitrogen, ; e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
A61K 47/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Applicants
  • VACCINE STABILIZATION INSTITUTE [US]/[US]
Inventors
  • CHANG, Byeong Seon
  • OH, Jeong S.
Agents
  • FLEMING, James F.
  • ENTRALTA P.C.
Priority Data
62/774,04730.11.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) VIRAL FORMULATIONS CONTAINING AMINO ACIDS
(FR) FORMULATIONS VIRALES CONTENANT DES ACIDES AMINÉS
Abstract
(EN)
Provided are stable virus formulations that contain at least three amino acids, at least one protein, at least one carbohydrate, and at least one salt. In certain embodiments, amino acid combinations with either at least three, or four, or more amino acids are included. By virtue of inclusion of the amino acids, a virus in the formulations is physically and biologically stable both in liquid and dry powder state. In further embodiments, by virtue of inclusion of the amino acids, a virus in the formulations is physically and biologically stable during lyophilization process. In further embodiments, by virtue of inclusion of the amino acids, a virus in the formulations is physically and biologically stable during storage in both liquid and lyophilized states.
(FR)
L'invention concerne des formulations de virus stables qui contiennent au moins trois acides aminés, au moins une protéine, au moins un glucide et au moins un sel. Dans certains modes de réalisation, les combinaisons d'acides aminés contiennent au moins trois, quatre acides aminés ou plus. Grâce à l'inclusion des acides aminés, un virus dans les formulations est physiquement et biologiquement stable à la fois à l'état liquide et de poudre sèche. Dans d'autres modes de réalisation, grâce à l'inclusion des acides aminés, un virus dans les formulations est stable physiquement et biologiquement, au cours du processus de lyophilisation. Dans d'autres modes de réalisation, grâce à l'inclusion des acides aminés, un virus, dans les formulations, est stable physiquement et biologiquement lorsqu'il est stocké à la fois à l'état liquide et lyophilisé.
Latest bibliographic data on file with the International Bureau